Patent Cliff and the Future of Generics in Asia

Trends that will Impact the Market in the Short Term


RELEASE DATE
19-Dec-2014
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P860-01-00-00-00
SKU
LS00147-AP-MR_16988
Yes
SHARE

Patent Cliff and the Future of Generics in Asia
Published on: 19-Dec-2014 | SKU: LS00147-AP-MR_16988

Need more details?
$2,450.00
DownloadLink
Need more details?

The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a significant percentage of products to the US and Europe. India, China, South Korea, and Japan are the important Asian markets. The generics industry has moved on after patent cliff, and is more focused on increasing product quality and market share. Overall, the global generics market will see an average growth in the next 2-3 years.

Executive Summary

Executive Summary (continued)

Executive Summary (continued)

Executive Summary (continued)

Executive Summary (continued)

Key Questions This Study Will Answer

Research Process and Methodology

What Will The Global Generics Market Look Like in 2015?

What Can We Expect in the Next Three Years?

Opportunities by Therapeutic Segments—Cardiovascular Disease Remains the Most Attractive Segment till 2018

Opportunities by Product Segments—Biologics or Oral Solids?

With Less Molecules To Lose Exclusivity, Will the Generics Industry Continue To Grow?

Major Losses Due To Patent Cliff in 2014

Selected Patent Expiries in 2015

Who Gets the Maximum Advantage Post Loss of Exclusivity (LOE) of Major Drugs?

Challenges for Drug Manufacturers

Major Models and Trends Post 2012 LOE

Activities in the Asian Generics Market

Major Approvals and New Products in Asia-Pacific Generics Market in 2014

Indian Generics Market

Indian Generics Market (continued)

Indian Market is Mix of Branded Generics and Un-branded Generics

Universal Health Coverage Scheme 2015–2019

Universal Health Coverage in India and its Implications

To Meet The Demands of Domestic Markets, Generic Manufacturers Have to Produce a Surplus

Markets Other than India to be Equally Lucrative for Generic Manufacturers

China

Chinese Generics Market in 2014

Generics Market Boom Likely in the Next 3 Years

Japan

LOE Scenario in Japanese Pharma Industry 2014–2015

Japanese Generics Market in 2014

Key Focus of Japanese Pharma Industry—“Quality”

The Philippines

Indonesia

Taiwan and Malaysia

Rest of Asia

India, Indonesia, Vietnam, and China to lead APAC

Strategies

First-mover Advantage: Case Study—Cymbalta

The Last Word

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related industry research

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: Facility Management in Malaysia, 2026

Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...

17 Sep 2026   |   Global   |   Market Research

Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029

The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: ASEAN Warehouse Automation System Providers, 2026

Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...

16 Sep 2026   |   North America   |   Customer Research

US Automotive Technicians’ Choice Survey, 2025

The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...

16 Sep 2026   |   Global   |   Market Research

Apple Performance Tracker, Q1 2026

This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a significant percentage of products to the US and Europe. India, China, South Korea, and Japan are the important Asian markets. The generics industry has moved on after patent cliff, and is more focused on increasing product quality and market share. Overall, the global generics market will see an average growth in the next 2-3 years.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Author Siddharth Dutta
WIP Number P860-01-00-00-00
Is Prebook No

Patent Cliff and the Future of Generics in Asia

$2,450.00
In stock
SKU
LS00147-AP-MR_16988